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Informed choice is important for screening, but not everyone wants or is able to analyse research 
data. Vikki Entwistle and colleagues propose a new approach to communication 
People are offered a wide range of screening tests by diverse providers. For example: maternal and 
child health services screen for genetic conditions and developmental problems; general 
practitioners screen for cardiovascular risk factors; NHS programmes screen for bowel, breast, and 
cervical cancer; and commercial providers offer various health assessments, including body and gene 
scans. Provision of tests is not well regulated, and there is a bewildering amount of information of 
variable accuracy in the public domain.1 
It is unclear how healthcare providers should communicate about screening in order to support 
appropriate uptake. And what constitutes appropriate uptake is also contested because of 
disagreements about the merits of particular tests and tensions between concerns to promote 
health and to respect autonomy.2 3 4 Debates about communication have tended to consider two 
types of approach, which we call “be screened’ and “analyse and choose.” We consider their 
problems and propose a third approach, “consider an offer.”  
 
Be screened 
The be screened approach aims to persuade people to have screening, usually with a view to 
promoting health gain, cost effective service provision, or proﬁt.2 3 4 Its key features are 
encouragement to be screened; an emphasis on the beneﬁts of screening and de-emphasis of 
potential harms; and a lack of recognition that it might be reasonable not to be screened. 
This approach is found in commercial advertisements and some invitations to participate in 
government funded screening programmes. For example, the leaﬂet Breast Cancer: the Facts, from 
the NHS Breast Cancer Screening Programme presents screening as necessary for women aged over 
50.5 It asks, “Should all women have breast screening?” and gives no hint of any scope for a negative 
answer. The leaﬂet highlights the beneﬁts of mammography and describes the main processes but 
plays down potential harms. It does not mention that screening may lead to overtreatment or that 
clinicians and epidemiologists seriously dispute the value of breast screening. It gives no indication 
that women might reasonably choose not to be screened, and includes a breast awareness code that 
instructs women to “Go for breast screening every 3 years if you are over 50.” 
The main criticisms of the be screened approach are that it inadequately reﬂects the beneﬁt-harm 
proﬁle of screening tests and fails to respect autonomy because it does not facilitate informed 
decision making by individuals.6 7 8 Some communications with features typical of this approach 
purport to facilitate informed choice, but they present only one option: to be screened.  
 
Analyse and choose 
The analyse and choose approach is one response to criticisms of the be screened approach. It 
emphasises respect for autonomy and treats this as a matter of ensuring that competent individuals 
have suﬃcient understanding of their options and can make intentional, suﬃciently independent 
choices.9 It assumes that suﬃcient understanding requires comprehension of detailed research 
based information about beneﬁts and harms and promotes informed individual decision making 
based on this. 
The key features of this approach are an emphasis on the importance of individual (sometimes 
independent) choice and the provision of comparative data about the various outcomes of screening 
and no screening. The approach is exempliﬁed by decision aids, which seek to present the data in 
accessible ways. 
There are three main criticisms of the analyse and choose approach. Firstly, the implication that 
everyone eligible for screening should consider detailed effectiveness data may be unnecessarily 
burdensome. This criticism is particularly strong when expert committees acting in the public 
interest have reviewed the available research, judged the tests to be broadly effective and 
acceptable, and supported the introduction of government endorsed screening programmes. 
Secondly, there are concerns that encouraging detailed decision analysis by individuals might not 
lead to good choices (it might disrupt people’s usual effective decision making processes) or deter 
uptake of effective, appropriate screening.4 7 10 11 Thirdly, some critics think this approach 
overemphasises rational and independent decision making —reﬂecting an inappropriately narrow 
understanding of autonomy.  
 
New considerations 
Recent research into decision making has highlighted some potential downsides of detailed decision 
analysis and maximising (aiming to make the best possible choice). It suggests that heuristics and 
“satisﬁcing” (aiming to make good enough choices) can be less burdensome and yield better 
decisions and outcomes.12 13 
The understanding of autonomy that prevails in health care has been criticised for focusing too 
narrowly on discrete decisions, over-idealising rationalism, and inappropriately assuming that 
interpersonal collaboration and trust will compromise rather than promote autonomy.14 15 16 
Although autonomy relates to individuals, it is both developed and exercised in the context of social 
relationships.16 17 18 People who use “intellectual outsourcing” to help shape their opinions, and 
who do not process detailed data for themselves before they choose or act, do not necessarily fail to 
exercise autonomy,18 although others who try to impose their views and discourage competent 
consideration of alternatives do tend to undermine it. 
Neither of the two approaches above considers the importance of the interests and trustworthiness 
of those who offer and advise about screening. This failing, together with recent evidence about 
what patients value about communication with health professionals19 and involvement in decision 
making,20 leads us to suggest a third approach to communication about screening.  
 
Consider an offer 
The consider an offer approach is designed to respect personal autonomy without overburdening 
people with unwanted information and decision making tasks and without deterring uptake of 
effective and personally appropriate screening. Within this approach, communicators either 
recommend or offer screening or help people to consider recommendations or offers from others. 
They openly explain and discuss the basis for the recommendation or offer; encourage and facilitate 
an individual assessment of the recommendation or offer (including consideration of the potential 
bias and trustworthiness of those making it and of its personal relevance); provide or facilitate 
access to further information if that is required; and acknowledge that the recommendation or offer 
might reasonably be refused. 
Just what information and how much detail are required will vary across screening tests, contexts, 
and individuals, but will usually include a summary of the potential beneﬁts and harms of the test 
considered, consideration of any known objections to it, information about test providers, and 
factors that might affect the appropriateness of the test for particular individuals (table⇓). The 
optional extra information might include detailed data on outcomes and, more controversially, other 
people’s experiences and preferences, especially in value laden contexts such as screening for fetal 
abnormality.7 
 
Illustration of communication by general practitioner consistent with consider an offer approach 
to screening 
Key communication topics 
 
Rationale Response to a healthy 45 
year old’s query about 
prostate cancer screening 
Recommendation of 
cardiovascular risk 
assessment 
Who made the 
recommendation or offer? 
 
Being able to depend on 
others appropriately is 
essential for autonomy.
16
 
Information about the 
individuals, committees, 
and organisations that 
recommend or offer 
screening can help people 
assess their trustworthiness 
and identify potential 
concerns about their 
recommendations or offers 
Although several men’s 
groups are campaigning for 
screening, the National 
Screening Committee, 
which is required to review 
the evidence very carefully, 
does not think that routine 
screening for prostate 
cancer is justified 
The National Institute for 
Health and Clinical 
Excellence and all the major 
professional and patient 
groups have worked 
together and now 
recommend that we carry 
out a cardiovascular risk 
assessment for most people 
aged 45 and over 
 
What is the basis of the 
recommendation, and what 
are the main benefits and 
harms of screening? 
 
An explanation of how a 
recommendation was 
reached may help people to 
assess its trustworthiness. 
Information about 
consequences is an 
important component of 
practical reasoning, and 
people usually want to 
know (or at least not be 
misled about) the main 
reasons for or against 
healthcare interventions 
Although prostate cancer 
kills many men, a lot of men 
have prostate cancer but do 
not die from it . . . Prostate 
specific antigen (PSA) 
testing will pick up some 
prostate cancers but will 
also miss some. And we 
can’t tell which of the 
prostate cancers that it does 
pick up would be life 
threatening. When a man is 
found to have prostate 
cancer after being screened, 
no one can be sure if 
current treatments will 
leave him better off than if 
he had not been screened. 
Research is ongoing, but at 
the moment we really don’t 
know the overall effects of 
Studies following thousands 
of people over several 
decades have allowed 
experts to develop accurate 
estimates of how likely 
individuals are to have a 
heart attack or stroke, 
based on their age, sex, 
family history, blood 
pressure, blood cholesterol, 
and whether they smoke. 
Many things can be done to 
reduce the risk and 
screening would allow us to 
discuss options appropriate 
for your level of risk 
PSA testing 
Are there any factors that 
make the screening test 
more appropriate for some 
people than others? 
Beyond a clear statement 
about who a 
recommendation or offer 
applies to, it may be useful 
to highlight circumstances 
that can make screening 
more or less appropriate for 
particular individuals—eg, 
age and risk exposures that 
modify the likelihood of 
benefit and values that can 
give people reason to 
accept or decline screening 
tests 
Prostate cancer is rare in 
men under 50 and you have 
no family history of prostate 
cancer, so the chances of 
you having it are relatively 
low. But if you are 
particularly anxious about it 
and concerned to find out, 
then we should take that 
into account—but still 
bearing in mind that the test 
is not 100% accurate and 
may lead to unnecessary 
treatment 
You’re a heavy smoker, 
which increases your risk of 
heart disease and stroke. If 
you’re worried about having 
a stroke like your uncle, 
screening might help us 
think again about the 
smoking and look at other 
ways you can reduce that 
risk 
Who might gain from 
screening and how are 
people protected? 
Information about the 
financial and other 
significant interests of the 
organisations and 
individuals that 
recommend, offer, and 
provide screening are 
relevant in some contexts 
Although I wouldn’t really 
recommend it, I can arrange 
for a PSA test for you on the 
NHS… You’ll find private 
health care providers more 
enthusiastic about the 
test—but then they can 
make money from it in a 
way that I can’t 
The income we get from 
government to help run the 
practice depends in part on 
us doing some of these 
checks, but we recommend 
it because we think it can 
help patients. The practice 
would still care for you if 
you chose not to be 
screened 
Is more information 
needed? 
People’s information needs 
vary. Initial communications 
can usefully encourage 
people to consider whether 
they have enough 
information and enable 
those who want more to 
access other potentially 
useful sources 
Has that given you enough 
information, or would you 
like more detail or more 
time to think about it? I 
have a leaflet here that 
summarises the information 
we’ve talked about, and it 
lists a few other sources of 
information 
Does that give you enough 
to go on? I can give you 
more information, or point 
you towards a website that 
explains the assessment in 
more detail 
 
When presented with a screening offer, people might reasonably respond in various ways. Some 
might judge the trustworthiness and personal relevance of a screening offer on the basis of the 
initial communication; others might habitually seek and follow the advice of a trusted health 
professional; and others might want to evaluate research evidence for themselves—at least for 
some tests. It should be feasible to respond to these varied preferences even when communications 
are necessarily standardised to some extent. For example, mailed invitations from national screening 
programmes can encourage people to consider whether they would like more information and tell 
them where to ﬁnd additional resources and personal support. 
This approach respects autonomy because it encourages and enables people to consider screening 
offers carefully. Although it can incorporate strong recommendations, it does not close down 
opportunities for thoughtful refusals of screening. For example, practitioners will avoid presenting 
screening as routine16 or necessary and will ensure people feel they can safely say they do not think 
a test is right for them. The consider an offer approach can facilitate informed decision making about 
screening, providing summary information about the beneﬁts and harms of screening to all and 
decision aids with more detailed epidemiological information to those who want them (ﬁgure), but it 
does not assume that autonomous choice or informed decision making will always require every 
individual to work through detailed statistics for themselves. 
 
Overview of the consider an offer approach 
 
Because it accepts the reality of intellectual outsourcing18 and the importance of trust, the consider 
an offer approach makes people vulnerable to manipulation: trust can be both inappropriately 
placed and abused.21 However, this vulnerability is arguably no greater than with the be screened 
approach. Consider an offer provides some protection by discussing the basis of recommendations 
or offers, facilitating assessment of the trustworthiness of those who make them, and raising 
questions about the adequacy of the information supplied. The further protection that the analyse 
and choose approach offers by encouraging rational personal decisions based on detailed data on 
outcomes is not practical for many. 
For screening programmes backed by agencies such as the National Screening Committee, the 
consider an offer approach should not adversely affect uptake of broadly effective tests. 
Communication consistent with this approach should help people to recognise when providers are 
trustworthy. In contrast, the be screened approach might lead to mistrust over time if people come 
to realise practitioners have underplayed the downsides of screening. 
The consider an offer approach is less demanding on those eligible for screening than the analyse 
and choose approach, but it puts more onus on providers to communicate in a range of ways to 
meet diverse information needs. Some programmes already use features of consider an offer—for 
example, information about newborn bloodspot tests presents recommendations and explanations 
and points out that tests are not compulsory.22 But if the approach is found to be successful, health 
service agencies will need to develop more resources to support adoption by front line health 
professionals.  
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